Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by fredgoodwinsonon Mar 20, 2020 2:34pm
207 Views
Post# 30831413

RE:RE:RE:RE:RE:RE:Breakthrough status and IND application

RE:RE:RE:RE:RE:RE:Breakthrough status and IND applicationWould like to know more Laser - and doubtless there is more to be told - but it will all come down to the results at the end of the Trial.

Sadly that is further down the road now. Little weight is generally given to interim data but results at Trial end for the first 12 could be noteworthy and positive to an extent that this relatively small number may be regarded as a meaningful sample and thereby a surrogate for the Trial as a whole - we will see. Anyway we know that the first 12 will all be treated twice and if those second treatments are all made safely it must narrow the odds of IND approval. Yes a positive ann IMHO.

Been here 6 years and no cheerleader for anyone. It will take as long as it takes and it will take a while yet. With this interruption think now looking to next year. Full results for the first 12 in tandem with the ann of a Phase IB in a non-superficial and deadly cancer could have this being looked at very differently and if you`re sold on the science and you believe that it will shortly be fully proven up the sp is a joke.








Bullboard Posts